Federal regulatory oversight of us clinics marketing adipose-derived autologous stem cell interventions: Insights from 3 new FDA draft guidance documents

  • Leigh G. Turner

Research output: Contribution to journal › Short survey › peer-review

30   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Federal regulatory oversight of us clinics marketing adipose-derived autologous stem cell interventions: Insights from 3 new FDA draft guidance documents'. Together they form a unique fingerprint.
Sort by